Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs KOPRAN. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA KOPRAN. BAL PHARMA/
KOPRAN.
 
P/E (TTM) x 40.8 30.9 132.4% View Chart
P/BV x 2.3 2.8 79.7% View Chart
Dividend Yield % 1.1 1.2 94.4%  

Financials

 BAL PHARMA   KOPRAN.
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
KOPRAN.
Mar-23
BAL PHARMA/
KOPRAN.
5-Yr Chart
Click to enlarge
High Rs134327 41.0%   
Low Rs6396 66.0%   
Sales per share (Unadj.) Rs193.9114.3 169.7%  
Earnings per share (Unadj.) Rs1.75.6 29.5%  
Cash flow per share (Unadj.) Rs7.58.3 90.4%  
Dividends per share (Unadj.) Rs1.003.00 33.3%  
Avg Dividend yield %1.01.4 71.5%  
Book value per share (Unadj.) Rs40.791.1 44.6%  
Shares outstanding (eoy) m15.6948.21 32.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.9 27.5%   
Avg P/E ratio x59.237.5 157.9%  
P/CF ratio (eoy) x13.225.5 51.6%  
Price / Book Value ratio x2.42.3 104.5%  
Dividend payout %59.953.1 112.8%   
Avg Mkt Cap Rs m1,54910,205 15.2%   
No. of employees `000NANA-   
Total wages/salary Rs m553499 110.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0425,510 55.2%  
Other income Rs m931 30.7%   
Total revenues Rs m3,0525,541 55.1%   
Gross profit Rs m253518 48.7%  
Depreciation Rs m91127 71.8%   
Interest Rs m12361 202.4%   
Profit before tax Rs m47361 13.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2188 24.1%   
Profit after tax Rs m26272 9.6%  
Gross profit margin %8.39.4 88.3%  
Effective tax rate %44.824.5 183.1%   
Net profit margin %0.94.9 17.4%  
BALANCE SHEET DATA
Current assets Rs m2,2823,991 57.2%   
Current liabilities Rs m2,0931,770 118.3%   
Net working cap to sales %6.240.3 15.3%  
Current ratio x1.12.3 48.3%  
Inventory Days Days811 72.0%  
Debtors Days Days1,1281,077 104.7%  
Net fixed assets Rs m8292,506 33.1%   
Share capital Rs m157482 32.5%   
"Free" reserves Rs m4813,910 12.3%   
Net worth Rs m6384,392 14.5%   
Long term debt Rs m305179 170.6%   
Total assets Rs m3,1106,497 47.9%  
Interest coverage x1.46.9 20.0%   
Debt to equity ratio x0.50 1,174.7%  
Sales to assets ratio x1.00.8 115.3%   
Return on assets %4.85.1 93.6%  
Return on equity %4.16.2 66.2%  
Return on capital %18.19.2 196.2%  
Exports to sales %66.444.7 148.5%   
Imports to sales %22.410.1 221.6%   
Exports (fob) Rs m2,0202,464 82.0%   
Imports (cif) Rs m683558 122.4%   
Fx inflow Rs m2,0202,464 82.0%   
Fx outflow Rs m716624 114.6%   
Net fx Rs m1,3051,840 70.9%   
CASH FLOW
From Operations Rs m-18340 -5.4%  
From Investments Rs m-222-127 175.4%  
From Financial Activity Rs m244-198 -123.0%  
Net Cashflow Rs m415 24.5%  

Share Holding

Indian Promoters % 47.1 44.5 105.8%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 0.1 0.6 21.0%  
FIIs % 0.1 0.5 27.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 55.5 87.9%  
Shareholders   15,060 51,636 29.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs KOPRAN.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs KOPRAN. Share Price Performance

Period BAL PHARMA KOPRAN. S&P BSE HEALTHCARE
1-Day -4.40% 4.62% 1.18%
1-Month -17.76% 4.47% -0.75%
1-Year 40.93% 162.07% 61.82%
3-Year CAGR 19.04% 36.17% 18.16%
5-Year CAGR 5.43% 45.30% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the KOPRAN. share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of KOPRAN. the stake stands at 44.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of KOPRAN..

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

KOPRAN. paid Rs 3.0, and its dividend payout ratio stood at 53.1%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of KOPRAN..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.